0 XP   0   0   0

Orexo AB ADR
Buy or Sell?

Welcome Invester! I guess you are interested in Orexo AB ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Orexo AB ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Orexo AB ADR even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Orexo AB ADR is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Orexo AB ADR. The closing price on 2022-09-28 was $2.1 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Orexo AB ADR Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Orexo AB ADR.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Orexo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Orexo to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -30.1% means that $-0.30 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Orexo AB ADR:

  • The MRQ is -24.2%. The company is making a huge loss. -2
  • The TTM is -30.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-24.2%TTM-30.1%+5.9%
TTM-30.1%YOY-40.8%+10.7%
TTM-30.1%5Y-3.3%-26.8%
5Y-3.3%10Y-3.3%+0.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.2%0.8%-25.0%
TTM-30.1%1.0%-31.1%
YOY-40.8%1.7%-42.5%
5Y-3.3%0.6%-3.9%
10Y-3.3%1.2%-4.5%
1.1.2. Return on Assets

Shows how efficient Orexo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Orexo to the Drug Manufacturers-Specialty & Generic industry mean.
  • -3.5% Return on Assets means that Orexo generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Orexo AB ADR:

  • The MRQ is -2.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.8%TTM-3.5%+0.7%
TTM-3.5%YOY-4.5%+1.0%
TTM-3.5%5Y0.1%-3.6%
5Y0.1%10Y0.0%+0.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.8%0.2%-3.0%
TTM-3.5%0.2%-3.7%
YOY-4.5%0.1%-4.6%
5Y0.1%-0.1%+0.2%
10Y0.0%0.2%-0.2%
1.1.3. Return on Equity

Shows how efficient Orexo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Orexo to the Drug Manufacturers-Specialty & Generic industry mean.
  • -11.6% Return on Equity means the company generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Orexo AB ADR:

  • The MRQ is -11.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.6%TTM-12.6%+1.0%
TTM-12.6%YOY-11.1%-1.4%
TTM-12.6%5Y-0.3%-12.3%
5Y-0.3%10Y-0.4%+0.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.6%0.8%-12.4%
TTM-12.6%0.6%-13.2%
YOY-11.1%0.6%-11.7%
5Y-0.3%0.1%-0.4%
10Y-0.4%0.5%-0.9%

1.2. Operating Efficiency of Orexo AB ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Orexo is operating .

  • Measures how much profit Orexo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Orexo to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -38.2% means the company generated $-0.38  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Orexo AB ADR:

  • The MRQ is -38.2%. The company is operating very inefficient. -2
  • The TTM is -33.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-38.2%TTM-33.7%-4.5%
TTM-33.7%YOY-22.3%-11.3%
TTM-33.7%5Y0.2%-33.9%
5Y0.2%10Y0.8%-0.6%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.2%3.5%-41.7%
TTM-33.7%2.3%-36.0%
YOY-22.3%3.9%-26.2%
5Y0.2%3.5%-3.3%
10Y0.8%1.9%-1.1%
1.2.2. Operating Ratio

Measures how efficient Orexo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 148.0% means that the operating costs are $1.48for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Orexo AB ADR:

  • The MRQ is 1.480. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.487. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.480TTM1.487-0.007
TTM1.487YOY1.368+0.119
TTM1.4875Y1.183+0.304
5Y1.18310Y1.105+0.077
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4801.483-0.003
TTM1.4871.435+0.052
YOY1.3681.382-0.014
5Y1.1831.363-0.180
10Y1.1051.160-0.055

1.3. Liquidity of Orexo AB ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Orexo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 204.6% means the company has $2.05 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Orexo AB ADR:

  • The MRQ is 2.046. The company is able to pay all its short-term debts. +1
  • The TTM is 2.306. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.046TTM2.306-0.260
TTM2.306YOY2.352-0.046
TTM2.3065Y2.253+0.052
5Y2.25310Y2.229+0.024
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0461.887+0.159
TTM2.3061.900+0.406
YOY2.3522.104+0.248
5Y2.2532.156+0.097
10Y2.2291.840+0.389
1.3.2. Quick Ratio

Measures if Orexo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 128.4% means the company can pay off $1.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Orexo AB ADR:

  • The MRQ is 1.284. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 0.857. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.284TTM0.857+0.426
TTM0.857YOY0.479+0.378
TTM0.8575Y0.601+0.256
5Y0.60110Y0.588+0.013
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2840.638+0.646
TTM0.8570.784+0.073
YOY0.4790.809-0.330
5Y0.6010.838-0.237
10Y0.5880.834-0.246

1.4. Solvency of Orexo AB ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Orexo assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.76 means that Orexo assets are financed with 75.7% credit (debt) and the remaining percentage (100% - 75.7%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Orexo AB ADR:

  • The MRQ is 0.757. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.724. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.757TTM0.724+0.033
TTM0.724YOY0.591+0.132
TTM0.7245Y0.633+0.091
5Y0.63310Y0.643-0.010
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7570.429+0.328
TTM0.7240.412+0.312
YOY0.5910.391+0.200
5Y0.6330.390+0.243
10Y0.6430.396+0.247
1.4.2. Debt to Equity Ratio

Measures if Orexo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 311.5% means that company has $3.11 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Orexo AB ADR:

  • The MRQ is 3.115. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.651. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.115TTM2.651+0.464
TTM2.651YOY1.490+1.161
TTM2.6515Y1.851+0.800
5Y1.85110Y1.925-0.074
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1150.695+2.420
TTM2.6510.677+1.974
YOY1.4900.624+0.866
5Y1.8510.678+1.173
10Y1.9250.689+1.236

2. Market Valuation of Orexo AB ADR

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Orexo.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.45 means the investor is paying $-0.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Orexo AB ADR:

  • The EOD is -0.407. Company is losing money. -2
  • The MRQ is -0.445. Company is losing money. -2
  • The TTM is -0.547. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.407MRQ-0.445+0.039
MRQ-0.445TTM-0.547+0.102
TTM-0.547YOY13.407-13.954
TTM-0.5475Y7.940-8.487
5Y7.94010Y6.904+1.036
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4070.342-0.749
MRQ-0.4450.416-0.861
TTM-0.5471.360-1.907
YOY13.4073.493+9.914
5Y7.9406.176+1.764
10Y6.9046.811+0.093
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Orexo.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Orexo AB ADR:

  • The MRQ is 0.017. Very good. +2
  • The TTM is -0.010. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ0.017TTM-0.010+0.027
TTM-0.010YOY-0.165+0.156
TTM-0.0105Y-0.025+0.016
5Y-0.02510Y-0.0250.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0170.003+0.014
TTM-0.0100.020-0.030
YOY-0.1650.032-0.197
5Y-0.0250.026-0.051
10Y-0.0250.028-0.053

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Orexo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.26 means the investor is paying $0.26 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Orexo AB ADR:

  • The EOD is 0.234. Very good. +2
  • The MRQ is 0.256. Very good. +2
  • The TTM is 0.320. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.234MRQ0.256-0.022
MRQ0.256TTM0.320-0.065
TTM0.320YOY0.329-0.008
TTM0.3205Y0.158+0.162
5Y0.15810Y0.138+0.021
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.2341.442-1.208
MRQ0.2561.617-1.361
TTM0.3202.042-1.722
YOY0.3292.274-1.945
5Y0.1582.006-1.848
10Y0.1381.538-1.400

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Orexo AB ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Gains Per Share---0.610-1.102+80%-2.026+232%0.817-175%0.817-175%
Book Value Per Share--8.98810.193-12%15.834-43%8.427+7%7.328+23%
Current Ratio--2.0462.306-11%2.352-13%2.253-9%2.229-8%
Debt To Asset Ratio--0.7570.724+5%0.591+28%0.633+20%0.643+18%
Debt To Equity Ratio--3.1152.651+17%1.490+109%1.851+68%1.925+62%
Dividend Per Share----0%-0%-0%-0%
Eps---1.042-1.291+24%-1.747+68%-0.420-60%-0.366-65%
Gains Per Share---0.610-1.102+80%-2.026+232%0.817-175%0.817-175%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.242-0.301+24%-0.408+68%-0.033-86%-0.033-86%
Operating Margin---0.382-0.337-12%-0.223-41%0.002-18196%0.008-4738%
Operating Ratio--1.4801.4870%1.368+8%1.183+25%1.105+34%
Pb Ratio0.234-10%0.2560.320-20%0.329-22%0.158+62%0.138+86%
Pe Ratio-0.407+9%-0.445-0.547+23%13.407-103%7.940-106%6.904-106%
Peg Ratio--0.017-0.010+158%-0.165+1069%-0.025+249%-0.025+249%
Price Per Share2.100-10%2.3003.302-30%5.189-56%3.791-39%3.297-30%
Quick Ratio--1.2840.857+50%0.479+168%0.601+114%0.588+118%
Return On Assets---0.028-0.035+23%-0.045+61%0.001-2841%0.000-8278%
Return On Equity---0.116-0.126+8%-0.111-4%-0.003-98%-0.004-96%
 EOD+2 -1MRQTTM+10 -7YOY+9 -85Y+4 -1310Y+4 -13

3.2. Fundamental Score

Let's check the fundamental score of Orexo AB ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.407
Price to Book Ratio (EOD)Between0-10.234
Net Profit Margin (MRQ)Greater than0-0.242
Operating Margin (MRQ)Greater than0-0.382
Quick Ratio (MRQ)Greater than11.284
Current Ratio (MRQ)Greater than12.046
Debt to Asset Ratio (MRQ)Less than10.757
Debt to Equity Ratio (MRQ)Less than13.115
Return on Equity (MRQ)Greater than0.15-0.116
Return on Assets (MRQ)Greater than0.05-0.028
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Orexo AB ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.962
Ma 20Greater thanMa 502.209
Ma 50Greater thanMa 1002.363
Ma 100Greater thanMa 2002.245
OpenGreater thanClose2.100
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Net Interest Income  -10,80010,700-100-21,800-21,90020,000-1,90014,20012,300



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,271,000
Total Liabilities962,100
Total Stockholder Equity308,900
 As reported
Total Liabilities 962,100
Total Stockholder Equity+ 308,900
Total Assets = 1,271,000

Assets

Total Assets1,271,000
Total Current Assets882,000
Long-term Assets882,000
Total Current Assets
Cash And Cash Equivalents 244,200
Short-term Investments 223,500
Net Receivables 329,900
Inventory 84,400
Total Current Assets  (as reported)882,000
Total Current Assets  (calculated)882,000
+/-0
Long-term Assets
Property Plant Equipment 121,600
Other Assets 31,000
Long-term Assets  (as reported)389,000
Long-term Assets  (calculated)152,600
+/- 236,400

Liabilities & Shareholders' Equity

Total Current Liabilities431,100
Long-term Liabilities531,000
Total Stockholder Equity308,900
Total Current Liabilities
Other Current Liabilities 249,200
Total Current Liabilities  (as reported)431,100
Total Current Liabilities  (calculated)249,200
+/- 181,900
Long-term Liabilities
Long term Debt 493,500
Capital Lease Obligations Min Short Term Debt50,800
Other Liabilities 7,300
Long-term Liabilities  (as reported)531,000
Long-term Liabilities  (calculated)551,600
+/- 20,600
Total Stockholder Equity
Common Stock308,900
Total Stockholder Equity (as reported)308,900
Total Stockholder Equity (calculated)308,900
+/-0
Other
Common Stock Shares Outstanding 34,368
Net Debt 249,300
Net Invested Capital 802,400
Net Tangible Assets 73,400
Net Working Capital 450,900



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
112,100
104,800
976,200
1,033,300
1,003,900
1,035,400
1,173,500
1,208,300
1,286,700
1,367,400
1,440,100
1,545,300
1,501,100
1,550,400
1,463,000
1,328,200
1,232,900
1,433,500
1,344,900
1,312,100
1,273,700
1,205,700
1,271,000
1,271,0001,205,7001,273,7001,312,1001,344,9001,433,5001,232,9001,328,2001,463,0001,550,4001,501,1001,545,3001,440,1001,367,4001,286,7001,208,3001,173,5001,035,4001,003,9001,033,300976,200104,800112,100
   > Total Current Assets 
91,800
85,100
805,000
850,800
827,400
860,800
997,800
994,400
1,059,500
1,065,900
1,138,700
1,236,400
1,221,200
1,243,000
1,057,000
927,200
831,600
1,024,500
943,900
892,900
865,500
813,400
882,000
882,000813,400865,500892,900943,9001,024,500831,600927,2001,057,0001,243,0001,221,2001,236,4001,138,7001,065,9001,059,500994,400997,800860,800827,400850,800805,00085,10091,800
       Cash And Cash Equivalents 
31,100
28,100
294,300
370,700
327,900
437,500
494,800
516,600
589,800
647,400
697,000
812,900
816,800
861,400
677,200
593,300
505,300
725,500
679,700
588,100
504,100
437,800
244,200
244,200437,800504,100588,100679,700725,500505,300593,300677,200861,400816,800812,900697,000647,400589,800516,600494,800437,500327,900370,700294,30028,10031,100
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
223,500
223,5000000000000000000000000
       Net Receivables 
20,300
21,500
217,800
208,000
245,200
217,200
308,800
297,300
292,000
252,200
291,100
286,400
261,100
241,600
253,600
213,200
207,500
190,200
168,500
211,500
256,700
298,000
329,900
329,900298,000256,700211,500168,500190,200207,500213,200253,600241,600261,100286,400291,100252,200292,000297,300308,800217,200245,200208,000217,80021,50020,300
       Inventory 
37,900
35,500
292,900
272,100
250,200
206,100
194,200
180,500
173,600
166,400
150,600
137,000
131,800
140,100
126,200
120,700
108,400
108,800
95,700
93,400
92,300
77,600
84,400
84,40077,60092,30093,40095,700108,800108,400120,700126,200140,100131,800137,000150,600166,400173,600180,500194,200206,100250,200272,100292,90035,50037,900
       Other Current Assets 
2,500
0
0
0
0
0
0
0
0
-100
0
100
100
-100
0
0
100
0
0
-100
-100
0
0
00-100-1000010000-1001001000-100000000002,500
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
301,500
301,400
309,000
279,900
307,300
406,000
401,000
401,300
409,000
401,000
419,200
408,200
392,200
389,000
389,000392,200408,200419,200401,000409,000401,300401,000406,000307,300279,900309,000301,400301,500000000000
       Property Plant Equipment 
2,400
2,400
20,800
20,000
20,100
19,400
20,300
19,500
20,000
87,700
84,900
84,000
79,000
101,000
93,600
106,200
115,100
119,200
124,300
123,600
125,100
123,200
121,600
121,600123,200125,100123,600124,300119,200115,100106,20093,600101,00079,00084,00084,90087,70020,00019,50020,30019,40020,10020,00020,8002,4002,400
       Long Term Investments 
0
0
0
7,000
7,100
7,300
7,800
7,700
10,400
10,800
10,800
12,300
1,400
0
0
0
0
0
0
0
0
0
0
00000000001,40012,30010,80010,80010,4007,7007,8007,3007,1007,000000
       Intangible Assets 
15,200
15,000
129,800
125,400
121,000
116,600
112,100
108,300
103,900
99,700
95,500
101,900
114,000
0
0
0
234,300
0
0
0
248,800
0
0
00248,800000234,300000114,000101,90095,50099,700103,900108,300112,100116,600121,000125,400129,80015,00015,200
       Other Assets 
0
21,100
20,600
30,100
28,300
31,300
35,500
78,400
92,900
103,300
110,200
110,700
85,600
95,000
98,100
54,400
32,700
35,800
25,300
34,200
33,400
26,600
31,000
31,00026,60033,40034,20025,30035,80032,70054,40098,10095,00085,600110,700110,200103,30092,90078,40035,50031,30028,30030,10020,60021,1000
> Total Liabilities 
78,000
74,200
700,400
733,300
674,800
730,000
812,200
783,900
810,600
870,800
887,200
873,600
794,700
775,100
727,500
708,800
674,400
898,700
885,500
900,400
924,100
876,200
962,100
962,100876,200924,100900,400885,500898,700674,400708,800727,500775,100794,700873,600887,200870,800810,600783,900812,200730,000674,800733,300700,40074,20078,000
   > Total Current Liabilities 
34,100
36,100
699,800
730,000
349,900
404,800
488,500
457,100
483,400
496,900
516,000
537,900
461,000
461,600
444,500
407,000
601,300
344,600
340,300
356,600
380,200
339,500
431,100
431,100339,500380,200356,600340,300344,600601,300407,000444,500461,600461,000537,900516,000496,900483,400457,100488,500404,800349,900730,000699,80036,10034,100
       Short-term Debt 
0
339,400
340,000
340,600
319,100
319,500
319,800
0
0
19,900
196,900
0
0
0
0
0
0
0
0
0
0
0
0
000000000000196,90019,90000319,800319,500319,100340,600340,000339,4000
       Short Long Term Debt 
0
339,400
340,000
340,600
319,100
319,500
319,800
0
0
19,900
196,900
0
0
0
0
0
224,500
154,900
0
0
0
0
0
00000154,900224,50000000196,90019,90000319,800319,500319,100340,600340,000339,4000
       Accounts payable 
14,900
0
0
0
45,500
0
0
0
47,700
0
0
0
49,400
0
0
0
47,000
0
0
0
49,200
0
0
0049,20000047,00000049,40000047,70000045,50000014,900
       Other Current Liabilities 
19,200
36,100
359,800
182,200
14,200
143,200
180,600
191,100
4,900
190,500
-100
234,400
4,700
157,500
194,800
186,900
6,200
154,900
146,200
192,500
13,300
172,400
249,200
249,200172,40013,300192,500146,200154,9006,200186,900194,800157,5004,700234,400-100190,5004,900191,100180,600143,20014,200182,200359,80036,10019,200
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
373,900
371,200
335,700
333,700
313,500
283,000
301,800
73,100
554,100
545,200
543,800
543,900
536,700
531,000
531,000536,700543,900543,800545,200554,10073,100301,800283,000313,500333,700335,700371,200373,900000000000
       Capital Lease Obligations Min Short Term Debt
0
-339,400
-340,000
-340,600
-319,100
-319,500
-319,800
0
0
45,300
-134,100
59,800
54,700
74,400
68,600
63,300
66,500
63,200
63,400
61,100
58,200
54,000
50,800
50,80054,00058,20061,10063,40063,20066,50063,30068,60074,40054,70059,800-134,10045,30000-319,800-319,500-319,100-340,600-340,000-339,4000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
-100
100
0
100
0
-100
0
0
100
100
0
100
100
0
0100100010010000-10001000100-100000000000
> Total Stockholder Equity
34,200
30,600
275,800
300,000
329,100
305,400
361,300
424,400
476,100
496,600
552,900
671,700
706,400
775,300
735,500
619,400
558,500
534,800
459,400
411,700
349,600
329,500
308,900
308,900329,500349,600411,700459,400534,800558,500619,400735,500775,300706,400671,700552,900496,600476,100424,400361,300305,400329,100300,000275,80030,60034,200
   Common Stock
1,500
273,300
275,800
300,000
14,100
305,400
361,300
424,400
14,200
496,600
552,900
671,700
14,200
775,300
735,500
619,400
14,200
534,800
459,400
411,700
14,200
329,500
308,900
308,900329,50014,200411,700459,400534,80014,200619,400735,500775,30014,200671,700552,900496,60014,200424,400361,300305,40014,100300,000275,800273,3001,500
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
-7,300
0
0
0
-300
0
0
0
3,100
0
0
0
-13,400
0
0
0
-400
0
0
00-400000-13,4000003,100000-300000-7,3000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue565,000
Cost of Revenue-78,900
Gross Profit486,100486,100
 
Operating Income (+$)
Gross Profit486,100
Operating Expense-789,900
Operating Income-224,900-303,800
 
Operating Expense (+$)
Research Development272,300
Selling General Administrative431,900
Selling And Marketing Expenses-
Operating Expense789,900704,200
 
Net Interest Income (+$)
Interest Income0
Interest Expense-28,200
Net Interest Income-28,200-28,200
 
Pretax Income (+$)
Operating Income-224,900
Net Interest Income-28,200
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-222,500-224,900
EBIT - interestExpense = -246,200
-222,500
-195,300
Interest Expense28,200
Earnings Before Interest and Taxes (ebit)-218,000-194,300
Earnings Before Interest and Taxes (ebitda)-141,300
 
After tax Income (+$)
Income Before Tax-222,500
Tax Provision-1,000
Net Income From Continuing Ops-223,500-223,500
Net Income-223,500
Net Income Applicable To Common Shares-223,500
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-100
Total Other Income/Expenses Net-28,200
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
UPAB.AS
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UPAB.AS.

UPAB.AS Daily Candlestick Chart
PFE.XETRA
21 minutes ago

I found you a Death Cross on the daily chart of PFE.XETRA.

PFE.XETRA Daily Candlestick Chart
IS0X.XETRA
27 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IS0X.XETRA.

IS0X.XETRA Daily Candlestick Chart
IS0S.XETRA
27 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IS0S.XETRA.

IS0S.XETRA Daily Candlestick Chart
XUEK.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XUEK.XETRA.

XUEK.XETRA Daily Candlestick Chart
IBC9.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IBC9.XETRA.

IBC9.XETRA Daily Candlestick Chart
XMK9.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XMK9.XETRA.

XMK9.XETRA Daily Candlestick Chart
XAIX.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XAIX.XETRA.

XAIX.XETRA Daily Candlestick Chart
EUN1.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EUN1.XETRA.

EUN1.XETRA Daily Candlestick Chart
EMNE.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EMNE.XETRA.

EMNE.XETRA Daily Candlestick Chart
DX2D.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DX2D.XETRA.

DX2D.XETRA Daily Candlestick Chart
36B5.XETRA
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 36B5.XETRA.

36B5.XETRA Daily Candlestick Chart
AWSR.LSE
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AWSR.LSE.

AWSR.LSE Daily Candlestick Chart
AWSG.LSE
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AWSG.LSE.

AWSG.LSE Daily Candlestick Chart
CI2U.LSE
30 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CI2U.LSE.

CI2U.LSE Daily Candlestick Chart
VFEM.LSE
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VFEM.LSE.

VFEM.LSE Daily Candlestick Chart
ROBO.LSE
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ROBO.LSE.

ROBO.LSE Daily Candlestick Chart
ARIX.LSE
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ARIX.LSE.

ARIX.LSE Daily Candlestick Chart
UETW.XETRA
34 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UETW.XETRA.

UETW.XETRA Daily Candlestick Chart
PLUN.XETRA
34 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PLUN.XETRA.

PLUN.XETRA Daily Candlestick Chart
LYYA.XETRA
34 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LYYA.XETRA.

LYYA.XETRA Daily Candlestick Chart
IUSP.XETRA
34 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IUSP.XETRA.

IUSP.XETRA Daily Candlestick Chart
SXR3.XETRA
34 minutes ago

I found you a Death Cross on the daily chart of SXR3.XETRA.

SXR3.XETRA Daily Candlestick Chart
EDM4.XETRA
34 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EDM4.XETRA.

EDM4.XETRA Daily Candlestick Chart
LYM8.XETRA
36 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LYM8.XETRA.

LYM8.XETRA Daily Candlestick Chart